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Accepted 27 November 2009AbstractObjective: To determine the impact of the clinical and embryological factors on the pregnancy outcome of frozenethawed embryo transfer.
Materials and Methods: The data of 247 frozenethawed embryo transfer cycles were assessed at Royan Institute from March 2006 to March
2008. Appropriate statistical analysis was performed using Student t test and Chi-square or Fisher exact test. Forward logistic regression was
done to predict the individual impact of factors on the success of frozen embryo transfer.
Results: According to our results, 1,523 frozen embryos were thawed with a survival rate of 79.8%. The overall chemical and clinical pregnancy
rates per embryo transfer cycle were 28.1% and 26.3%, respectively. A total of 71 gestational sacs were implanted (7.9%). The pregnancy
outcome was higher in women who were stimulated with the gonadotrophin releasing hormone agonist long protocol, treated by a combination
of follicle stimulating hormone and luteinizing hormone, who had endometrial thickness greater than or equal to 8 mm on the embryo transfer
day, and who had positive fresh-cycle pregnancy test.
Conclusion: Protocol type, gonadotrophin preparations, fresh-cycle outcome, endometrial thickness and the numbers of obtained oocytes,
embryos, and high-quality thawed embryos transferred are the factors affecting pregnancy outcome of frozenethawed embryo transfer.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Cryopreserved embryo transfer cycle is an advantage for
women who produce large numbers of oocytes and embryos in
their fresh in vitro fertilization (IVF) cycle [1,2]. Lowering the
risk of multiple pregnancy [3] and ovarian hyperstimulation
syndrome [4e7]; providing cost effectiveness [7] and almost
stress-free procedure for couples [1,8]; giving the chance of* Corresponding author. Endocrinology and Female Infertility Department,
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doi:10.1016/j.tjog.2011.01.037donating embryos to other couples with a genetic disease or to
women with premature ovarian failure; arranging the oppor-
tunity for couples to have an additional child [7]; increasing the
take-home baby [9,10] and cumulative pregnancy rates [11,12]
are all important advantages of embryo cryopreservation that
persuade IVF centers to use this service for couples. On the
other hand, several investigators have detected lower implan-
tation and pregnancy rates in frozenethawed embryo
replacement cycles compared with fresh IVF cycles [13e15],
and two important etiologies of this lowered rate are (1)
adverse effect of the freezeethawing process and ice crystal
damage and (2) transferring higher-quality embryos in the fresh
cycle and freezing the lower-grade ones [16]. The question that
comes to mind is whether there is any way to improve thecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Impact of clinical factors (age, gonadotrophin, protocol, infertility etiology,
endometrial thickness, and fresh-cycle b-hCG result) on the embryo cryo-
preservation outcome
Clinical factors Implantation rate % (n) Clinical pregnancy % (n)
Age (yr)
40 7.9 (67/847) 26.3 (54/205)
>40 7.7 (4/52) 25 (3/12)
Gonadotrophin
FSH 5.3 (22/413)* 18 (18/100)
FSHþ LH 16.9 (11/65)* 37.5 (6/16)
FSHþ LHþHCG 8.4 (21/249)* 30 (18/60)
NA 17/172 17/41
Protocol
Long 8.5 (69/813)* 27.8 (55/198)
Antagonist 2.3 (2/86)* 10.5 (2/19)
Infertility etiology
PCO 7.4 (23/312) 25.3 (19/75)
Non-PCO 8.2 (48/587) 26.8 (38/142)
Endometrial thickness** (mm)
8 8.6 (67/779) 28.2 (53/188)
<8 0 (0/36) 0 (0/9)
NA 4/84 4/20
Fresh-cycle b-hCG
Positive 14 (19/136)* 42.9 (15/35)*
Negative 6.5 (44/680)* 22.2 (36/162)*
NA 8/83 6/20
*A p value 0.05.
**p¼ 0.065.
b-hCG¼ b-Human Chorionic Gonadotropin; FSH¼ follicle stimulating
hormone; LH¼ luteinizing hormone; NA¼ not available (unregistered infor-
mation in the patients’ files); PCO¼ polycystic ovary syndrome.
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A few studies have assessed the clinical and embryological
factors affecting pregnancy outcome [1,13,17,18], and there is
controversy about the parameters among the performed studies.
This retrospective study has been scheduled in our center for
a better understanding about some of the clinical and embry-
ological factors that may influence pregnancy outcome and to
apply more measurements for promoting the pregnancy
outcome of frozenethawed embryo transfer cycles.
Materials and methods
All infertility cases who underwent IVF or intracytoplasmic
sperm injection (ICSI) treatment at Royan Institute (Infertility
and Reproductive Medicine Research Centre) and had cry-
opreserved embryo transfer were reviewed retrospectively.
From March 2006 to March 2008, 297 cycles were identified.
The cycles were excluded if (1) the cause of infertility was
uterine factor; (2) the embryos were acquired from donated
oocytes; (3) endometrial preparation was performed in
a natural cycle; and (4) the couples had more than three ART
cycles. Women with pituitary downregulation and “long or
antagonist protocols,” who agreed on cryopreservation of the
additional retrieved embryos, were included in our study.
Finally, 247 cycles were included in this study according to the
mentioned inclusion and exclusion criteria.
After ovarian stimulation and oocyte retrieval, which was
described previously [19], embryos were produced by IVF or
ICSI procedures. The generated embryos were assessed and
graded as A, B, and C, according to their morphology,
cleavage stage, and fragmentation rate [20]. The remaining
embryos were cryopreserved on Day 2 or 3 after IVF or ICSI.
The procedure used for embryo cryopreservation in patients
with surplus excellent- or good-quality embryos was slow
freezing [21]. At the time of frozen embryo transfer, the
embryos were thawed, and those with at least 50% of the
blastomeres intact were selected for intrauterine transfer
without any interference from the embryologists. The selected
embryos were transferred into 50-mL embryo Glue (Vitrolife,
Sweden) for 2 hours before intrauterine transfer.
For the endometrial preparation, estradiol valerate (Abur-
aihan, Tehran, Iran) 4 mg/d was given and continued until the
optimal endometrial thickness was obtained. Intramuscular
progesterone 100 mg (Aburaihan, Tehran, Iran) was given, and
embryo transfer was performed 3 days later. Between one and
six embryos were transferred according to the age, number of
unsuccessful outcomes of the IVF or ICSI cycles, and quality of
embryos. The patients were tested using serum b-human cho-
rionic gonadotropin (b-hCG) assay 15 days after embryo
transfer, and if the pregnancy test was positive, a prescription of
estradiol valerate (6 mg/d) and progesterone (800 mg/d) was
continued until 12 weeks of gestation.
Chemical pregnancy was determined by the number of
positive b-hCG results. The clinical pregnancy was clarified
by the number of women with gestational sacs on transvaginal
sonography at 4e6 weeks of gestation. In the calculation of
implantation, the number of gestational sacs was considered.This study was approved by the Royan Ethics Committee, and
all couples gave an informed consent for using their infor-
mation for analysis before starting their treatment.
Data analysis was performed by means of the SPSS version
13.0 software program (SPSS Inc., Chicago, IL, USA).
Appropriate statistical analysis was performed using Student
t test, Chi-square test, and Fisher exact test. A p value less than
0.05 was considered statistically significant. Forward logistic
regression was performed to predict the individual impact of
factors on the success of frozen embryo transfer. Odds ratios
(ORs) with 95% confidence intervals (CIs) were calculated.
Results
A total of 222 patients who underwent 247 frozen embryo
transfer cycles were included in this study. The patient’s mean
age was 30.6 5.3 years (range, 17e45 years). The total
number of obtained embryos was 2,687, of which 2,010 were
frozen. One thousand five hundred twenty-three out of 2,010
frozen embryos were thawed, with a survival rate of 79.8%
(1,215 embryos survived), and 899 embryos were transferred
(74% transfer rate). The mean number of embryos transferred
was 3.6 per cycle (range, 1e6 per cycle), and the median
storage time was 170 days (range, 53e1,671 days).
According to our analysis, positive b-hCG results were seen
in 61 (Vitrolife, Sweden) cycles. The overall chemical and
Table 3
The forward logistic regression analysis with odds ratios and 95% confidence
intervals on the factors affecting the b-hCG result [oocyte retrieval, embryo
retrieval, and quality of embryo (Grade A)] after frozenethawed embryo
transfer
Variables b SE p OR 95% CI for OR
Lower Upper
Oocyte retrival 0.086 0.032 0.007 0.918 0.863 0.976
Retrieval embryo 0.107 0.049 0.028 1.113 1.011 1.226
Quality of embryo
transferred (Grade A)
0.234 0.100 0.020 1.263 1.038 1.538
Adapted from Refs. [4e7,40]
CI¼ confidence interval; OR¼ odds ratio; SE¼ standard error.
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(61 of 217) and 26.3% (57 of 217), respectively. A total of 71
gestational sacs were observed by ultrasonography (implan-
tation rate of 7.9%). The number of singletons was 45
(78.9%), and multiple pregnancies were observed in 21.1%
(17.6% twins and 3.5% triplets).
Table 1 indicates the main pregnancy outcomes of the
cryopreserved embryo transfer cycles separately stratified by
age, type of gonadotrophin, protocol type, infertility etiology,
endometrial thickness, and the result of fresh-cycle b-hCG
test. Statistical analysis indicated that there were no differ-
ences in implantation and clinical pregnancy rates between the
two maternal age groups (40 years and >40 years).
The implantation rate in women stimulated with gonado-
trophin releasing hormone agonist long protocol was higher
than that in the patients stimulated with antagonist protocol
(p< 0.05), and in comparison with the different gonadotro-
phin preparations, women previously treated by follicle stim-
ulating hormone (FSH)þ luteinizing hormone had a better
implantation rate (p< 0.05). There were no significant
differences in pregnancy outcomes between women with
polycystic ovary syndrome and those without polycystic ovary
syndrome.
Our results indicated that women with an endometrial
thickness greater than or equal to 8 mm on the embryo transfer
day had higher rates of clinical pregnancy and implantation as
compared with those with a lesser endometrial thickness
(<8 mm), but this difference was not statistically significant
(p¼ 0.06). The results also showed that endometrial thickness
negatively correlated with the maximal dosages of estradiol
(E2) (r¼0.321, p< 0.0001).
With regard to our findings, pregnancy in the fresh embryo
transfer cycle had a statistically significant effect on pregnancy
outcome in the freeze cycle, as the rates of implantation and
clinical pregnancy were higher in women with a positive
previous fresh-cycle b-hCG test (p< 0.05). The method of
fertilization, storage time, number of embryos transferred, andTable 2
Impact of embryological factors (number of embryos transferred, storage time,
method of fertilization, and assisted hatching) on the embryo cryopreservation
outcome
Embryological factors Implantation rate % (n) Clinical pregnancy % (n)
Number of embryos transferred
1e3 10.9 (13/119) 20 (9/45)
4 7.4 (58/780) 27.9 (48/172)
Storage duration (d)
180 6.5 (33/506) 22.7 (27/119)
>180 9.7 (38/393) 30.6 (30/98)
Method of fertilization
ICSI 8.3 (49/592) 27.4 (40/146)
IVF 8.3 (5/60) 28.6 (4/14)
IVF/ICSI 6.9 (17/247) 22.8 (13/57)
Assisted hatching
Yes 7.8 (65/829) 25.5 (51/200)
No 8.6 (6/70) 35.3 (6/17)
ICSI¼ intracytoplasmic sperm injection; IVF¼ in vitro fertilization.assisted hatching were factors that we assessed, and they were
found not to be associated with pregnancy outcomes of cry-
opreserved embryo transfer (Table 2).
We also performed forward logistic regression for all
clinical and embryological factors that we assumed to have an
influence on b-hCG result. According to the results, the
number of retrieval oocytes, the number of retrieval embryos,
and high quality of embryos transferred (Grade A) were
important factors predicting a positive b-hCG test in cry-
opreserved embryo cycles (Table 3). The OR calculated for
a positive hCG result for oocyte retrieval was 0.918 (95% CI,
0.863e0.976). Women with a lower number of retrieved
oocytes had more chance to have a positive b-hCG result. Our
analyses showed that the mean numbers of retrieved oocytes
in women with positive b-hCG and women with negative
b-hCG results were 16.4 6.6 and 18.7 7.7, respectively
(p< 0.05). In the evaluation of embryo quality, transferred
embryos with a higher quality (Grade A) was also another
factor that predicted a positive b-hCG result (OR, 1.263; 95%
CI, 1.038e1.538). The computed OR for the positive b-hCG
for embryo retrieval was 1.113 (95% CI, 1.011e1.226).
Discussion
In this retrospective study, we assessed the outcome of
cycles after frozenethawed embryo transfers and also the
clinical and embryological factors affecting the pregnancy
outcome of embryo cryopreservation.
Our data showed that the overall clinical pregnancy rate
was 26.3%, which is comparable to those in some other
studies [12,22e24]. However, our implantation rate per
transfer was lower than those in these studies (7.9%). The
reason for this decrease is the high number of embryo transfers
in our center during this time (range, 1e6).
Some large studies have shown that the female’s age has
a converse effect on the pregnancy and implantation rates [10].
However, we did not find such significant differences in
pregnancy outcome in the two maternal age groups (40 years
and >40 years). This finding shows that if we have enough
good-quality eggs and embryos, the age does not have an
effect on pregnancy outcome.
As anticipated, our results indicated better implantation rate
in women stimulated with the GnRH agonist long protocol
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after stimulation with the GnRH agonist long protocol, a large
amount of oocytes are obtained in women with normal ovaries,
and large numbers of embryos are provided for embryo transfer
or freezing. Consequently, significantly lower cancellation and
higher pregnancy rates are observed in the long protocol in
comparison with those of other stimulation protocols [25e27].
Oehninger et al [17] reported higher pregnancy and implan-
tation rates in women stimulated with the long protocol
than those in women with GnRH agonist stop protocol in
freezingethawing embryo transfer cycles. Other researchers
have reported no significant differences in implantation rates
between GnRH agonist and GnRH antagonist protocols after
cryopreserved embryo transfer [28,29].
We also found a significantly higher implantation rate in
women treated with LHeFSH than those treated with only
FSH or a combination of luteinizing hormone, FSH, and hCG.
However, other studies noted similar implantation rate among
different preparations of gonadotrophin [17,28].
Endometrial thickness is a major factor in identifying the
time of progesterone supplementation and frozenethawed
embryo transfer [24,30]. More studies have evaluated the
relationship between endometrial thickness and treatment
outcome after fresh IVF cycles and reported significantly
higher pregnancy rate in women with endometrial thickness
greater than or equal to 9 mm on hCG or embryo transfer day
in comparison with that in women with an endometrial
thickness of 7e8 mm [24,31,32]. In another study, no differ-
ences were found in pregnancy outcome in women with
endometrial thickness less than or equal to 8 mm and those
with endometrial thickness of 9e14 mm [33]. In our study,
none of the women with endometrial thickness less than 8 mm
became pregnant, although this finding was not statistically
significant (p¼ 0.06).
Similar to the study by Check et al [33], in the present
study, no differences were found in pregnancy outcomes
according to the maximal daily E2 dosages. However, there
was a significantly poor converse correlation between endo-
metrial thickness and total dosages of E2, showing the resis-
tance of women consuming higher dosages of E2 to
endometrial thickness, which is comparable to that in the study
by Check et al.
Our observation demonstrated that patients with a positive
b-hCG result in the fresh cycles were more likely to have
a positive outcome in the cryopreserved embryo transfer
cycles than patients with a negative b-hCG result. Wang et al
[10] retrospectively analyzed 3,570 frozen embryo cycles and
discovered higher implantation rate among younger women
with a previous positive pregnancy test. Conversely, another
study has reported impaired implantation rate for patients who
became pregnant in their fresh treatment cycle [1].
Simon et al [34], in a retrospective study, indicated
impaired clinical pregnancy rates for patients with frozen
embryo transfer who used ICSI in their fresh cycle. With
regard to our study, no differences were found in pregnancy
outcomes according to the method of fertilization. Similarly,
several investigators have failed to detect any significantdifferences in implantation or clinical pregnancy rates in
cycles in which IVF or ICSI was used for fertilization
[1,15,16,35]. This finding shows that the pregnancy outcome is
independent from fertilization method.
Storage time was another factor that was assessed. On the
basis of our data, there was no significant difference in preg-
nancy outcome according to the duration of cryopreservation.
Wang et al [10] reported a nonsignificant improved implan-
tation rate in patients with longer storage time (more than 2
years), which, from their point of view, was because of the
confounding effect of women who became pregnant in their
fresh cycle. In another study performed by Singh et al [1], the
storage time was comparable between patients with positive
and negative pregnancy results.
Analysis of our data also indicated that the number of
retrieval oocytes has a converse impact on the b-hCG result. It
means that with increasing number of oocytes, the chance of
pregnancy decreases. This suggests that with increasing
number of oocytes, the quality may reduce.
Another factor that had a direct impact on the b-hCG result
was the number of higher-quality transferred embryos (Grade
A). Salumets et al [12] have, in fact, reported significantly
higher implantation rates in those who had higher quality of
embryo transfer (Grade A or B) than in those with poor-quality
embryo transfer. The adverse effect of cryopreservation on
pregnancy outcome by crystal damage has been demonstrated
by several investigators [3,16]. Selick et al [3] evaluated the
effect of cryopreservation on embryo quality and pregnancy
outcome of embryos in fresh and frozen ovum recipient from
the same donor and discovered that cryopreservation has
a detrimental effect on embryo quality, but the rates of
implantation or pregnancy are not impaired after transfer of
high quality of embryos.
According to the results of other investigators, there is
a controversy among studies in the relationship between the
number of embryos transferred and pregnancy outcome. Some
researchers have reported a higher pregnancy rate with greater
number of embryos transferred [12,23], and other studies fail
this relationship [36]. In the present study, the rate of preg-
nancy outcome was calculated for a one- to three-embryo
transfer because of the small number of one- and two-embryo
transfers. Our data showed no differences in pregnancy
outcomes between women with a one- to three-embryo transfer
and those with an embryo transfer greater than or equal to four.
The analysis of our study showed that laser-assisted
hatching has no impact on the rates of pregnancy outcome.
However, in the present study, the number of women for
whom laser-assisted hatching had not been performed was
small. Some studies reported higher clinical pregnancy and
implantation rates for women who had assisted hatching
protocol than those in nonhatched women [37,38]. In another
study by Valojerdi et al [21], the impact of assisted hatching
on pregnancy outcome in women 37 years or older was
discovered. Conversely, Ng et al [39], in a randomized double-
blind controlled study, observed that laser-assisted hatching
did not improve the implantation rate after cryopreserved
embryo transfer.
163M. Ashrafi et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 159e164In conclusion, protocol type, gonadotrophin preparations,
outcome of the previous fresh cycle, endometrial thickness,
number of obtained oocytes, retrieval embryo, and the number
of high-quality thawed embryos transferred (Grade A) are the
factors that have an effect on pregnancy outcome of fro-
zenethawed embryo transfer.
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